RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:FDA guides on how AA can be converted to full approval.Under the new FDA guidance and the "one-trial approach, an accelerated approval would be sought alongside the registration of what would be considered a Phase 3/4 clinical study AND I would think that ONCY's potential Big Pharma would want to be responsible for such registration action as they would want to be responsible for the design, implemention and control of such a critical late stage clinical study.
So I think of Big Pharma ultimately navigating the final registration steps for ONCY's breast and pancreatic cancer studies along with others that have been identified as potential winners for BP.